You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CK-301

Showing 1 - 25 of 562
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Non-squamous Non Small Cell Lung Cancer Trial in Worldwide (Cosibelimab, Cisplatin, Carboplatin)

Active, not recruiting
  • Metastatic Non-squamous Non Small Cell Lung Cancer
  • Vitória, Brazil
  • +21 more
Aug 17, 2022

Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Worldwide (CK-301 (cosibelimab))

Recruiting
  • Lung Neoplasms
  • +12 more
  • CK-301 (cosibelimab)
  • Wollongong, New South Wales, Australia
  • +47 more
Mar 3, 2022

Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil, Placebo)

Recruiting
  • Paroxysmal Supraventricular Tachycardia
  • Phoenix, Arizona
  • +84 more
Sep 20, 2021

Pompe Disease Infantile-Onset Trial in China (GC301)

Not yet recruiting
  • Pompe Disease Infantile-Onset
  • GC301
  • Beijing, China
  • +4 more
Apr 2, 2023

Chronic Lung Disease Trial in New Taipei City (Standard pulmonnary rehabilitation, Nutritional supplementation intervention)

Recruiting
  • Chronic Lung Disease
  • Standard pulmonnary rehabilitation
  • Nutritional supplementation intervention
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Oct 29, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)

Recruiting
  • Healthy Participants
  • Tempe, Arizona
    Celerion
May 17, 2023

Chronic Pulmonary Disease Trial in New Taipei City (Music therapy)

Recruiting
  • Chronic Pulmonary Disease
  • Music therapy
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Dec 22, 2022

Infantile-onset Pompe Disease Trial in Beijing (Genetic: GC301)

Recruiting
  • Infantile-onset Pompe Disease
  • Genetic: GC301
  • Beijing, Beijing, China
    Bayi Children's Hospital, Seventh Medical Center, PLA general ho
Sep 30, 2022

Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)

Recruiting
  • Healthy Participants
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc.
Dec 20, 2022

Aortic Aneurysm Trial in New Taipei City (historical control, 3D printed lesion model)

Not yet recruiting
  • Aortic Aneurysm
  • historical control
  • 3D printed lesion model
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Nov 20, 2023

Systemic Lupus Erythematosus (SLE) Trial (BRL-301)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • BRL-301
  • (no location specified)
Aug 13, 2023

Medical Education Trial in New Taipei City (3D printed educational model, Tranditional model education)

Recruiting
  • Medical Education
  • 3D printed educational model
  • Tranditional model education
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Oct 28, 2023

Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)

Active, not recruiting
  • Cocaine Use Disorder
  • +2 more
  • Overland Park, Kansas
    Altasciences
Aug 29, 2023

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

Completed
  • Lung Neoplasms
  • +3 more
  • Sarasota, Florida
  • +19 more
Jul 25, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • +5 more
  • BRL-301
  • Shanghai, Shanghai, China
    Shanghai ChangZheng hospital
May 7, 2023

Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))

Enrolling by invitation
  • Symptomatic Hypertrophic Cardiomyopathy (HCM)
  • CK-3773274 (5 - 20 mg)
  • Los Angeles, California
  • +18 more
Jan 31, 2023

Healthy Trial in Edegem (CK-0045, Placebo)

Recruiting
  • Healthy
  • Edegem, Belgium
    SGS Clinical Research, Clinical Pharmacology Unit
Jan 26, 2023

Chronic Pulmonary Disease Trial in New Taipei City (Eccentric bike, Helmet ventilation)

Not yet recruiting
  • Chronic Pulmonary Disease
  • Eccentric bike
  • Helmet ventilation
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Feb 27, 2023

Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)

Not yet recruiting
  • Gastrointestinal Tumors
  • AZD6422 CLDN18.2 CAR-T product
  • Beijing, China
    Beijing Cancer Hospital
Aug 1, 2023

Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

Recruiting
  • Head Neck Cancer
  • Intratumoral Injection
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 28, 2023

Human Immunodeficiency Virus Trial run by the CC (Placebo, Pembrolizumab)

Recruiting
  • Human Immunodeficiency Virus
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023